Structure-Function Relationships in Factor IX and Factor IXa

By Schmidt A.E.   Bajaj S.P.  

Trends in Cardiovascular Medicine, Vol. 13, Iss. 1, 2003-01 ,pp. : 39-45

Elsevier

Access to resources Recommend Favorite

MEASUREMENT OF ANTI-FACTOR IX IGG SUBCLASSES IN HAEMOPHILIA B PATIENTS WHO DEVELOPED INHIBITORS WITH EPISODES OF ALLERGIC REACTIONS TO FACTOR IX CONCENTRATES

By Sawamoto Y.   Shima M.   Yamamoto M.   Kamisue S.   Nakai H.   Tanaka I.   Hayashi K.   Giddings J.C.   Yoshioka A.  

Thrombosis Research, Vol. 83, Iss. 4, 1996-08 ,pp. : 279-286

Elsevier

Access to resources Recommend Favorite

Assessment of Potential Thrombogenicity of Coagulation Factor IX Concentrates in an in Vitro Model of Human Thrombogenesis - Evidence from experimental studies using a perfusion technique

By Galan A.M.   Reverter J.C.   Bozzo J.   Hernandez M.R.   Escolar G.   Aznar-Salatti J.  

Thrombosis Research, Vol. 96, Iss. 5, 1999-12 ,pp. : 383-389

Elsevier

Access to resources Recommend Favorite

Comparing the Antithrombotic Efficacy of a Humanized Anti-factor IX(a) Monoclonal Antibody (SB 249417) to the Low Molecular Weight Heparin Enoxaparin In a Rat Model of Arterial Thrombosis

By Toomey J.R.   Blackburn M.N.   Storer B.L.   Valocik R.E.   Koster P.F.   Feuerstein G.Z.  

Thrombosis Research, Vol. 100, Iss. 1, 2000-10 ,pp. : 73-79

Elsevier

Access to resources Recommend Favorite

Discontinuous residues of factor IX constitute a surface for binding the anti-factor IX monoclonal antibody A-5

By Chang Y.-J.   Wu H.-L.   Hsu Y.-C.   Hamaguchi N.   Shi G.-Y.   Shen M.-C.   Lin S.-W.  

Thrombosis Research, Vol. 111, Iss. 4, 2003-01 ,pp. : 293-299

Elsevier

Access to resources Recommend Favorite